image
Healthcare - Biotechnology - NASDAQ - US
$ 1.13
-1.74 %
$ 5.07 M
Market Cap
-0.97
P/E
BALANCE SHEET
7.75 M ASSETS
-33.47%
1.57 M LIABILITIES
20.52%
6.18 M EQUITY
-40.27%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Silo Pharma, Inc.
image
Current Assets 7.68 M
Cash & Short-Term Investments 7.67 M
Receivables 0
Other Current Assets 16 K
Non-Current Assets 65 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 65 K
Current Liabilities 776 K
Accounts Payable 703 K
Short-Term Debt 0
Other Current Liabilities 72.1 K
Non-Current Liabilities 794 K
Long-Term Debt 0
Other Non-Current Liabilities 794 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
ASSETS
Cash & Cash Equivalents 3.5 11.4 9.8 1.1 0.1 0.3 0.3 0.6 0.7 1.7 2.0 279 1.75 K 47.5 K
Short Term Investments 4.1 3.12 K 0.4 200 9.39 K 0.2 1.3 0 0 0 0 0 0 0
Receivables 0 66 K 0 23.5 K 0.2 0 0 58.5 K 15.9 K 4.63 K 600 0 0 0
Inventory 0 0 61.2 K 33.5 K 0.2 27 K 0 0 0 0 0 0 0 0
Other Current Assets 16 K 0.1 0.1 0.2 16.3 K 34 K 1.4 27 K 20 K 18.9 K 0 0 0 0
Total Current Assets 7.7 11.6 10.4 1.4 0.5 0.6 1.6 0.7 0.8 1.8 2.0 279 1.75 K 47.5 K
PP&E 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 29.4 K 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 61.2 K 0 0 0.2 1.3 0.6 1.7 1.0 0.2 0 0 0
Other Long Term Assets 65 K 70.8 K 26.7 K 0 0 0 0 0 0 0 0 0 0 47.5 K
Other Assets 1 0 0 0 0 0 (1.3) 0 0 0 0 0 0 47.5 K
Total Assets 7.7 11.6 10.5 1.4 0.5 0.9 1.6 1.3 2.5 2.8 2.2 279 1.75 K 47.5 K
LIABILITIES
Accounts Payable 0.7 0.4 0.4 0.1 54.9 K 25.6 K 38.3 K 53.1 K 90.8 K 0 3.72 K 20.7 K 3.5 K 0
Short Term Debt 0 0 0 14.7 K 61.9 K 22.3 K 0 0 0 0 15 K 5 K 0 0
Other Current Liabilities 0 0 0 0 0 0 0 0 0 2.55 K 1.67 K 0 0 0
Total Current Liabilities 0.8 0.4 0.5 0.1 0.1 48 K 38.3 K 53.1 K 90.8 K 2.55 K 17 K 25.7 K 3.5 K 0
Long Term Debt 0 0 0 4.25 K 0 0 0 0 0 0 0 15 K 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 782 0 0
Total Liabilities 1.6 1.3 1.4 0.1 0.5 0.4 0.4 0.5 0.5 0.4 0.4 41.5 K 3.5 K 0
EQUITY
Common Stock 316 316 9.86 K 8.51 K 2.36 K 2.34 K 5.01 K 5.01 K 5.06 K 5.06 K 4.06 K 3.06 K 3.06 K 3.06 K
Retained Earnings (10.9) (7.2) (3.3) (5.8) (2.7) (1.6) (0.5) (0.4) (0.4) (1.2) (1.2) (1.2) (1.1) (1.1)
Other Accumulative Comprehensive Income/Loss 6.23 K 0 0 0 (0.4) (0.4) (1.1) (0.6) (0.4) 0 32.9 K 0 0 0
Total Equity 6.2 10.3 9.1 1.3 22.9 K 0.4 1.2 0.8 2.0 2.4 1.8 41.2 K 1.75 K 47.5 K
Total Liabilities and Equity 7.7 11.6 10.5 1.4 0.5 0.9 1.6 1.3 2.5 2.8 2.2 279 1.75 K 47.5 K
SHARES OUTSTANDING
Common Shares Outstanding 3.1 2.3 1.9 1.3 0.8 1.0 1.0 1.0 1.0 1.0 0.6 0.6 0.6